Company Pharma Nord Srl with Fiscal Code 16772678
recorded a turnover of 2024 of
968.666,
with a net profit of
37.198
and having an average number of employees of
7.
The company operates in the field of Activităţi de consultanţă în afaceri și management having the NACE code 7020.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Pharma Nord Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
263.132
237.486
528.151
546.883
593.915
786.199
767.270
747.593
866.881
968.666
Total Income - EUR
263.236
237.627
528.611
547.413
594.859
790.780
787.915
748.604
871.837
970.473
Total Expenses - EUR
256.626
231.243
512.424
530.638
577.384
767.620
764.154
725.401
835.920
919.022
Gross Profit/Loss - EUR
6.610
6.384
16.186
16.775
17.474
23.160
23.761
23.203
35.918
51.451
Net Profit/Loss - EUR
6.610
6.384
12.443
12.463
12.789
14.384
16.070
15.729
8.701
37.198
Employees
2
2
6
8
8
10
9
7
6
7
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 12.4%, from 866.881 euro in the year 2023, to 968.666 euro in 2024.
The Net Profit increased by 28.546 euro, from 8.701 euro in 2023, to 37.198 in the last year.
Check the financial reports for the company - Pharma Nord Srl
Financial Rating - Pharma Nord SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Pharma Nord Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Pharma Nord Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Pharma Nord Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Pharma Nord Srl - CUI 16772678
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
0
17.806
47.209
39.616
44.518
45.910
31.226
20.672
12.927
6.176
Current Assets
367.475
309.114
511.615
750.069
582.421
827.822
1.057.551
634.200
567.289
891.771
Inventories
54.289
82.629
103.022
232.688
249.024
141.637
280.491
236.905
154.462
98.507
Receivables
255.341
185.951
385.794
444.845
258.033
609.108
761.254
377.721
335.934
751.916
Cash
57.845
40.535
22.799
72.537
75.364
77.077
15.806
19.574
76.893
41.348
Shareholders Funds
17.893
24.095
36.130
24.971
26.740
40.617
35.925
35.747
13.648
42.117
Social Capital
4.587
4.540
4.464
4.382
4.297
4.215
4.122
4.135
4.122
4.099
Debts
350.856
304.921
524.290
766.427
600.927
834.154
1.047.756
611.004
558.399
846.228
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"7020 - 7020"
CAEN Financial Year
7022
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
891.771 euro in 2024 which includes Inventories of
98.507 euro, Receivables of
751.916 euro and cash availability of
41.348 euro.
The company's Equity was valued at
42.117 euro, while total Liabilities amounted to
846.228 euro.
Equity increased by 28.546 euro, from 13.648 euro in 2023, to 42.117 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Pharma Nord Srl